IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $588,864 | +13.8% | 12,982 | +3.0% | 0.00% | – |
| Q2 2023 | $517,265 | +10.0% | 12,607 | -4.2% | 0.00% | – |
| Q1 2023 | $470,446 | -59.7% | 13,163 | -57.4% | 0.00% | -100.0% |
| Q4 2022 | $1,166,035 | +161.4% | 30,872 | +206.3% | 0.00% | – |
| Q3 2022 | $446,000 | +64.0% | 10,079 | +37.0% | 0.00% | – |
| Q2 2022 | $272,000 | +31.4% | 7,355 | +31.5% | 0.00% | – |
| Q1 2022 | $207,000 | -96.9% | 5,594 | -97.2% | 0.00% | -100.0% |
| Q3 2021 | $6,686,000 | -25.9% | 199,346 | -11.9% | 0.01% | -16.7% |
| Q2 2021 | $9,022,000 | -78.7% | 226,180 | -76.0% | 0.01% | -80.6% |
| Q1 2021 | $42,383,000 | -39.8% | 942,678 | -24.3% | 0.03% | -43.6% |
| Q4 2020 | $70,366,000 | +11.0% | 1,244,530 | -6.8% | 0.06% | -1.8% |
| Q3 2020 | $63,379,000 | -25.8% | 1,335,714 | -7.7% | 0.06% | -30.9% |
| Q2 2020 | $85,368,000 | +28.3% | 1,447,882 | +2.9% | 0.08% | +2.5% |
| Q1 2020 | $66,553,000 | -22.2% | 1,407,628 | -0.6% | 0.08% | -2.5% |
| Q4 2019 | $85,558,000 | +4.1% | 1,416,285 | +3.2% | 0.08% | -1.2% |
| Q3 2019 | $82,185,000 | -6.6% | 1,371,814 | +0.2% | 0.08% | -6.8% |
| Q2 2019 | $88,016,000 | -16.6% | 1,369,476 | +5.3% | 0.09% | -17.8% |
| Q1 2019 | $105,552,000 | +21.7% | 1,300,380 | -19.0% | 0.11% | +8.1% |
| Q4 2018 | $86,765,000 | +41.3% | 1,604,974 | +34.8% | 0.10% | +65.0% |
| Q3 2018 | $61,417,000 | +24.4% | 1,190,719 | +0.5% | 0.06% | +20.0% |
| Q2 2018 | $49,387,000 | -5.0% | 1,185,182 | +0.5% | 0.05% | -5.7% |
| Q1 2018 | $51,967,000 | -12.5% | 1,178,916 | -0.2% | 0.05% | -10.2% |
| Q4 2017 | $59,410,000 | +2.4% | 1,181,109 | +3.2% | 0.06% | 0.0% |
| Q3 2017 | $58,027,000 | +32.6% | 1,144,526 | +33.0% | 0.06% | +31.1% |
| Q2 2017 | $43,761,000 | +26.3% | 860,260 | -0.2% | 0.04% | +25.0% |
| Q1 2017 | $34,651,000 | +1.2% | 861,957 | +20.4% | 0.04% | -2.7% |
| Q4 2016 | $34,251,000 | +47.2% | 716,107 | +12.7% | 0.04% | +42.3% |
| Q3 2016 | $23,274,000 | +56.9% | 635,195 | -0.3% | 0.03% | +52.9% |
| Q2 2016 | $14,831,000 | -34.6% | 636,805 | +13.8% | 0.02% | -34.6% |
| Q1 2016 | $22,673,000 | -28.2% | 559,818 | +9.7% | 0.03% | -29.7% |
| Q4 2015 | $31,600,000 | – | 510,253 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |